vs
Healthpeak Properties（DOC）与ICU MEDICAL INC（ICUI）财务数据对比。点击上方公司名可切换其他公司
Healthpeak Properties的季度营收约是ICU MEDICAL INC的1.3倍（$719.4M vs $540.7M），Healthpeak Properties净利率更高（73.2% vs -2.9%，领先76.1%），Healthpeak Properties同比增速更快（3.1% vs -14.1%），Healthpeak Properties自由现金流更多（$357.0M vs $36.0M），过去两年Healthpeak Properties的营收复合增速更高（8.9% vs -2.3%）
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
DOC vs ICUI — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $719.4M | $540.7M |
| 净利润 | $114.0M | $-15.7M |
| 毛利率 | — | 37.5% |
| 营业利润率 | 17.4% | 1.0% |
| 净利率 | 73.2% | -2.9% |
| 营收同比 | 3.1% | -14.1% |
| 净利润同比 | 2406.4% | 34.0% |
| 每股收益（稀释后） | $0.16 | $-0.63 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $719.4M | $540.7M | ||
| Q3 25 | $705.9M | $537.0M | ||
| Q2 25 | $694.3M | $548.9M | ||
| Q1 25 | $702.9M | $604.7M | ||
| Q4 24 | $698.0M | $629.8M | ||
| Q3 24 | $700.4M | $589.1M | ||
| Q2 24 | $695.5M | $596.5M | ||
| Q1 24 | $606.6M | $566.7M |
| Q4 25 | $114.0M | $-15.7M | ||
| Q3 25 | $-117.1M | $-3.4M | ||
| Q2 25 | $31.7M | $35.3M | ||
| Q1 25 | $42.8M | $-15.5M | ||
| Q4 24 | $4.5M | $-23.8M | ||
| Q3 24 | $85.9M | $-33.0M | ||
| Q2 24 | $146.0M | $-21.4M | ||
| Q1 24 | $6.7M | $-39.5M |
| Q4 25 | — | 37.5% | ||
| Q3 25 | 58.6% | 37.4% | ||
| Q2 25 | 60.2% | 37.9% | ||
| Q1 25 | 61.1% | 34.7% | ||
| Q4 24 | 60.3% | 36.1% | ||
| Q3 24 | 60.0% | 34.8% | ||
| Q2 24 | 60.6% | 34.8% | ||
| Q1 24 | 59.8% | 32.7% |
| Q4 25 | 17.4% | 1.0% | ||
| Q3 25 | 9.2% | 2.6% | ||
| Q2 25 | 5.7% | 1.9% | ||
| Q1 25 | 7.7% | 2.1% | ||
| Q4 24 | -2.2% | 6.0% | ||
| Q3 24 | 14.1% | 1.4% | ||
| Q2 24 | 22.3% | 1.3% | ||
| Q1 24 | 3.7% | -1.9% |
| Q4 25 | 73.2% | -2.9% | ||
| Q3 25 | -16.6% | -0.6% | ||
| Q2 25 | 4.6% | 6.4% | ||
| Q1 25 | 6.1% | -2.6% | ||
| Q4 24 | 0.7% | -3.8% | ||
| Q3 24 | 12.3% | -5.6% | ||
| Q2 24 | 21.0% | -3.6% | ||
| Q1 24 | 1.1% | -7.0% |
| Q4 25 | $0.16 | $-0.63 | ||
| Q3 25 | $-0.17 | $-0.14 | ||
| Q2 25 | $0.05 | $1.43 | ||
| Q1 25 | $0.06 | $-0.63 | ||
| Q4 24 | $0.02 | $-0.97 | ||
| Q3 24 | $0.12 | $-1.35 | ||
| Q2 24 | $0.21 | $-0.88 | ||
| Q1 24 | $0.01 | $-1.63 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $467.5M | — |
| 总债务越低越好 | $9.8B | — |
| 股东权益账面价值 | $7.5B | $2.1B |
| 总资产 | $20.3B | $4.1B |
| 负债/权益比越低杠杆越低 | 1.31× | — |
8季度趋势，按日历期对齐
| Q4 25 | $467.5M | — | ||
| Q3 25 | $91.0M | — | ||
| Q2 25 | $89.4M | — | ||
| Q1 25 | $70.6M | — | ||
| Q4 24 | $119.8M | $308.6M | ||
| Q3 24 | $180.4M | $312.5M | ||
| Q2 24 | $106.9M | $302.6M | ||
| Q1 24 | $101.8M | $251.4M |
| Q4 25 | $9.8B | — | ||
| Q3 25 | $9.1B | — | ||
| Q2 25 | $9.0B | — | ||
| Q1 25 | $8.9B | — | ||
| Q4 24 | $8.7B | — | ||
| Q3 24 | $8.6B | — | ||
| Q2 24 | $8.6B | — | ||
| Q1 24 | $8.8B | — |
| Q4 25 | $7.5B | $2.1B | ||
| Q3 25 | $7.6B | $2.1B | ||
| Q2 25 | $7.9B | $2.1B | ||
| Q1 25 | $8.2B | $2.0B | ||
| Q4 24 | $8.4B | $2.0B | ||
| Q3 24 | $8.6B | $2.0B | ||
| Q2 24 | $8.8B | $2.0B | ||
| Q1 24 | $8.9B | $2.1B |
| Q4 25 | $20.3B | $4.1B | ||
| Q3 25 | $19.6B | $4.1B | ||
| Q2 25 | $19.8B | $4.1B | ||
| Q1 25 | $19.8B | $4.2B | ||
| Q4 24 | $19.9B | $4.2B | ||
| Q3 24 | $20.0B | $4.3B | ||
| Q2 24 | $20.2B | $4.3B | ||
| Q1 24 | $20.5B | $4.3B |
| Q4 25 | 1.31× | — | ||
| Q3 25 | 1.20× | — | ||
| Q2 25 | 1.14× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 1.04× | — | ||
| Q3 24 | 1.00× | — | ||
| Q2 24 | 0.98× | — | ||
| Q1 24 | 0.99× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.3B | $60.6M |
| 自由现金流经营现金流 - 资本支出 | $357.0M | $36.0M |
| 自由现金流率自由现金流/营收 | 49.6% | 6.6% |
| 资本支出强度资本支出/营收 | 124.4% | 4.6% |
| 现金转化率经营现金流/净利润 | 10.99× | — |
| 过去12个月自由现金流最近4个季度 | — | $91.8M |
8季度趋势，按日历期对齐
| Q4 25 | $1.3B | $60.6M | ||
| Q3 25 | $315.0M | $56.7M | ||
| Q2 25 | $363.5M | $11.2M | ||
| Q1 25 | $279.4M | $51.3M | ||
| Q4 24 | $1.1B | $40.2M | ||
| Q3 24 | $318.2M | $36.1M | ||
| Q2 24 | $316.2M | $82.0M | ||
| Q1 24 | $152.6M | $45.8M |
| Q4 25 | $357.0M | $36.0M | ||
| Q3 25 | — | $27.6M | ||
| Q2 25 | — | $-8.5M | ||
| Q1 25 | — | $36.7M | ||
| Q4 24 | $333.7M | $16.1M | ||
| Q3 24 | — | $16.2M | ||
| Q2 24 | — | $62.5M | ||
| Q1 24 | — | $29.9M |
| Q4 25 | 49.6% | 6.6% | ||
| Q3 25 | — | 5.1% | ||
| Q2 25 | — | -1.5% | ||
| Q1 25 | — | 6.1% | ||
| Q4 24 | 47.8% | 2.6% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 10.5% | ||
| Q1 24 | — | 5.3% |
| Q4 25 | 124.4% | 4.6% | ||
| Q3 25 | — | 5.4% | ||
| Q2 25 | — | 3.6% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | 105.6% | 3.8% | ||
| Q3 24 | — | 3.4% | ||
| Q2 24 | — | 3.3% | ||
| Q1 24 | — | 2.8% |
| Q4 25 | 10.99× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 11.48× | 0.32× | ||
| Q1 25 | 6.52× | — | ||
| Q4 24 | 235.43× | — | ||
| Q3 24 | 3.71× | — | ||
| Q2 24 | 2.17× | — | ||
| Q1 24 | 22.85× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOC
暂无分部数据
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
